Related Experiment Video
Updated: Dec 21, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Coagulopathy in COVID-19: Manifestations and management
Simon R Mucha1,2, Siddharth Dugar3,4, Keith McCrae5,6
1Critical Care Medicine, Respiratory Institute, Cleveland Clinic.
Insights
Severe COVID-19 causes inflammation and blood clots. Patients with high D-dimer levels need aggressive prevention of venous thromboembolism and ultrasound screening.
Area of Science:
- Medicine
- Infectious Diseases
- Hematology
Background:
- Severe COVID-19 is linked to significant inflammation.
- This inflammation increases the risk of thrombotic complications, raising morbidity and mortality rates.
- Key laboratory findings include elevated D-dimer levels with normal fibrinogen in COVID-19-associated coagulopathy.
Purpose of the Study:
- To highlight the importance of venous thromboembolism prophylaxis in hospitalized COVID-19 patients.
- To recommend aggressive prophylaxis and screening for high-risk patients.
- To identify optimal imaging for high-risk individuals.
Main Methods:
- Review of laboratory findings in severe COVID-19.
- Analysis of D-dimer levels as a risk indicator.
- Evaluation of point-of-care ultrasonography for diagnosis.
Main Results:
- Elevated D-dimer (>3.0 μg/mL) indicates a need for intensified venous thromboembolism prophylaxis and screening.
- Point-of-care ultrasonography is identified as a safe and effective imaging choice for high-risk patients.
- This approach minimizes healthcare provider exposure to the virus.
Conclusions:
- Aggressive venous thromboembolism prophylaxis and screening are crucial for hospitalized COVID-19 patients with elevated D-dimer.
- Point-of-care ultrasonography is the preferred diagnostic tool for high-risk patients due to safety and efficiency.
- Management strategies should focus on mitigating thrombotic risks in severe COVID-19.
Abstract:
Severe COVID-19 illness is associated with intense inflammation, leading to high rates of thrombotic complications that increase morbidity and mortality. Markedly elevated levels of D-dimer with normal fibrinogen levels are the hallmark laboratory findings of severe COVID-19- associated coagulopathy. Prophylaxis against venous thromboembolism is paramount for all hospitalized patients, with more aggressive prophylaxis and screening recommended for patients with D-dimer levels above 3.0 μg/mL. Point-of-care ultrasonography is the imaging method of choice for patients at high risk, as it entails minimal risk of exposing providers to the virus.
Related Concept Videos
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism III: Nursing Management

